Cover Image

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

We report asialoglycoprotein receptor (ASGPR)-targeted doxorubicin hydrochloride (Dox) nanoparticles (NPs) for hepatocellular carcinoma (HCC). Polyethylene sebacate (PES)-Gantrez® AN 119 Dox NPs of average size 220 nm with PDI < 0.62 and ∼20% Dox loading were prepared by modified nanoprecipitatio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sandhya Pranatharthiharan (Author), Mitesh D. Patel (Author), Vinod C. Malshe (Author), Vaishali Pujari (Author), Ajit Gorakshakar (Author), Manisha Madkaikar (Author), Kanjaksha Ghosh (Author), Padma V. Devarajan (Author)
Format:	Book
Published:	Taylor & Francis Group, 2017-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor
by: Rensong Sun, et al.
Published: (2021)

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
by: Yu Xia, et al.
Published: (2019)

Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor
by: Juergen Scharner, et al.
Published: (2019)

The Roles of Doxorubicin in Hepatocellular Carcinoma
by: Kin Tam
Published: (2013)

Targeted and synergistic therapy for hepatocellular carcinoma: monosaccharide modified lipid nanoparticles for the co-delivery of doxorubicin and sorafenib
by: Duan W, et al.
Published: (2018)

Low-density lipoprotein decorated silica nanoparticles co-delivering sorafenib and doxorubicin for effective treatment of hepatocellular carcinoma
by: Junfeng Ye, et al.
Published: (2018)

Cascade screening for β-thalassemia: A practical approach for identifying and counseling carriers in India
by: Gorakshakar Ajit, et al.
Published: (2009)

Transferrin-Conjugated Polymeric Nanoparticle for Receptor-Mediated Delivery of Doxorubicin in Doxorubicin-Resistant Breast Cancer Cells
by: Zar Chi Soe, et al.
Published: (2019)

Burden of thalassemia in India: The road map for control
by: Roshan Colah, et al.
Published: (2017)

Targeted Doxorubicin-Loaded Dendronized Gold Nanoparticles
by: Lance T. Dockery, et al.
Published: (2023)

Effect and mechanism of protease inhibitor oprozomib on doxorubicin sensitivity of hepatocellular carcinoma cells
by: Feng Qi, et al.
Published: (2024)

Enhanced Intestinal Permeation of Doxorubicin Using Chitosan Nanoparticles
by: Marziyeh Zare, et al.
Published: (2018)

Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity
by: Silvia Voci, et al.
Published: (2023)

MiR-375 and Doxorubicin Co-delivered by Liposomes for Combination Therapy of Hepatocellular Carcinoma
by: Yin-Ping Fan, et al.
Published: (2017)

Effect of Proinflammatory Cytokines (IL-6, TNF-α, and IL-1β) on Clinical Manifestations in Indian SLE Patients
by: Vinod Umare, et al.
Published: (2014)

A Novel C@Fe@Cu Nanocomposite Loaded with Doxorubicin Tailored for the Treatment of Hepatocellular Carcinoma
by: Mohammed S. Saddik, et al.
Published: (2022)

Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
by: Baozhen Zhang, et al.
Published: (2018)

Hyaluronic acid-doxorubicin nanoparticles for targeted treatment of colorectal cancer
by: Daniel C. Pan, et al.
Published: (2021)

Anti-idiotype antibodies in immune regulation of ANCA associated vasculitis
by: Pradhan Vandana, et al.
Published: (2009)

Remembering Prof. K. C. Das
by: Neelam Varma, et al.
Published: (2015)

Nucleic acid amplification testing in Indian blood banks: A review with perspectives
by: Kanjaksha Ghosh, et al.
Published: (2017)

Report of proceedings of the national meeting on "Guidelines for Immunophenotyping of Hematolymphoid Neoplasms by Flow Cytometry"
by: Gujral Sumeet, et al.
Published: (2008)

Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
by: Yuan Lu, et al.
Published: (2021)

Mild Hyperthermia Responsive Liposomes for Enhanced In Vitro and In Vivo Anticancer Efficacy of Doxorubicin against Hepatocellular Carcinoma
by: Muhammad Abdur Rahim, et al.
Published: (2021)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
by: Yongwhan Choi, et al.
Published: (2020)

Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
by: Kamila Butowska, et al.
Published: (2023)

Chitosan/Alginate Nanogels Containing Multicore Magnetic Nanoparticles for Delivery of Doxorubicin
by: Sérgio R. S. Veloso, et al.
Published: (2023)

Hyaluronic Acid-Modified and Doxorubicin-Loaded Gold Nanoparticles and Evaluation of Their Bioactivity
by: Lin-Song Li, et al.
Published: (2021)

Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis
by: Maheshkumar P Soni, et al.
Published: (2014)

Exploring a four-gene risk model based on doxorubicin resistance-associated lncRNAs in hepatocellular carcinoma
by: Zunyi Zhang, et al.
Published: (2022)

Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma
by: Renna Qiu, et al.
Published: (2020)

Protective effects of psoralen polymer lipid nanoparticles on doxorubicin - induced myocardial toxicity
by: Fansu Meng, et al.
Published: (2022)

Dual-Targeted Hyaluronic Acid/Albumin Micelle-Like Nanoparticles for the Vectorization of Doxorubicin
by: Manuela Curcio, et al.
Published: (2021)

Doxorubicin and Varlitinib Delivery by Functionalized Gold Nanoparticles Against Human Pancreatic Adenocarcinoma
by: Sílvia Castro Coelho, et al.
Published: (2019)

Magnetoliposomes Based on Shape Anisotropic Calcium/Magnesium Ferrite Nanoparticles as Nanocarriers for Doxorubicin
by: Beatriz D. Cardoso, et al.
Published: (2021)

Regulation of drug release performance using mixed doxorubicin-doxorubicin dimer nanoparticles as a pH-triggered drug self-delivery system
by: Jiagen Li, et al.
Published: (2022)

Sustained-Release and pH-Adjusted Alginate Microspheres-Encapsulated Doxorubicin Inhibit the Viabilities in Hepatocellular Carcinoma-Derived Cells
by: Cheng-Tang Pan, et al.
Published: (2021)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
by: Su Jong Yu, et al.
Published: (2023)

Toxicity and Safety Evaluation of Doxorubicin-Loaded Cockleshell-Derived Calcium Carbonate Nanoparticle in Dogs
by: Abubakar Danmaigoro, et al.
Published: (2018)

Doxorubicin‐loaded nanoparticle coated with endothelial cells‐derived exosomes for immunogenic chemotherapy of glioblastoma
by: Chao Zhang, et al.
Published: (2021)